Ainos, Inc. (AIMD) · Nov 20, 2026 · Delisting

Ainos Nasdaq notice exposes equity shortfall, cure plan due Jan. 4

Nasdaq deficiency — $1.72M equity vs $2.50M Nasdaq minimum

Ainos’ Nasdaq notice formalizes a listing-compliance problem: equity is below the required minimum, forcing a financing or debt-conversion plan.

Ainos is trying to turn AI Nose deployments in semiconductor and industrial settings, alongside VELDONA licensing, into a commercial business; its latest quarter showed higher revenue but the company remains loss-making and dependent on additional financing.

The listing problem is now formal, not hypothetical. Nasdaq says Ainos fails the $2.5 million stockholders’ equity requirement, with only $1.721 million reported at September 30, 2026. The company also says it fails the two alternative standards, removing the simplest paths to remain compliant.

MeasureSeptember 30, 2026Nasdaq requirement
Stockholders’ equity (Balance Sheet)$1.72M$2.50M
Estimated shortfall$779K—

The immediate trading risk is limited, but the financing pressure is real. The notice does not immediately suspend trading, and Ainos has until January 4, 2027 to submit a recovery plan. But management is already considering converting debt into equity and pursuing other capital raises, which points to a need to repair the balance sheet before the business has generated enough operating strength to do so internally. 〔0〕 〔1〕

Most of the financial weakness was already visible in the recent 10-Q; the new information is the deadline and cure process. That makes this partly known rather than a surprise, but the formal Nasdaq notice converts a balance-sheet warning into a concrete listing-compliance test. There is no assurance Nasdaq accepts the plan, grants an extension, or that any financing can be completed on acceptable terms. 〔2〕

Bottom line: This does not delist Ainos today, but it confirms that the company’s commercialization story is now constrained by a balance-sheet and financing problem. The next meaningful test is whether it can present and execute a credible plan before the January 4 deadline.

What to watch next

Compliance plan due January 4, 2027

Original filing on SEC EDGAR

More Ainos, Inc. news

Ainos Nasdaq notice exposes equity shortfall, cure plan due Jan. 4 | AIMD Stock News
AllSight

Breaking down Wall Street's
information edge.

A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.

—
8-K events this week
—
filings analyzed in total
live · updated 30s ago
Live events · whole market · · --:--:-- ET
AllSight read
Straight from the 8-K
Verbatim from the filing AllSight decoded — highlighted above. Open on SEC EDGAR ↗
Limited-time offerFree 14-day Pro trial
AllSight

Sign in to AllSight

  • Follow any company — we email you the moment it files, free!
  • Your watchlist saved to your account, on every device — free!

by Signing in NOW, claim your FREE 14-day Pro trial!

No password. We email you a 6-digit code. By continuing you agree to our Terms & Privacy.
AllSight · Live plain-English 8-K decodes across the whole US market · Not investment advice.